EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Engineering artificial microbial consortia for personalized gut microbiome modulation and disease treatment

Timoth Mkilima iD

Annals of the New York Academy of Sciences · 2025

DOI: 10.1111/nyas.15352 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of the New York Academy of Sciences, 2025. Verfasst von Timoth Mkilima. Beteiligte Einrichtung: Department of Environmental Engineering and Management, The University of Dodoma, Dodoma, Tanzania. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Precision Medicine, Microbial Consortia. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 231 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human gut microbiome is a complex ecosystem that plays a vital role in maintaining health and contributing to the pathogenesis of various diseases. This review proposes a transformative approach that involves engineering artificial microbial consortia—precisely designed communities of microorganisms—for personalized modulation of the gut microbiome and targeted therapeutic interventions. By integrating synthetic biology, systems biology, and advanced culturing techniques, tailored microbial consortia can be developed to perform specific functions within the gut, including the production of therapeutic molecules, modulation of immune responses, and competition against pathogenic bacteria. In vitro and in vivo studies indicate that these engineered consortia can effectively restore microbial balance and enhance host resilience. This personalized approach holds immense potential to revolutionize healthcare by addressing the root causes of diseases such as metabolic disorders, inflammatory conditions, and gastrointestinal infections through precise manipulation of the gut microbiome. Future research should focus on rigorous clinical trials to evaluate the safety, efficacy, and long‐term impacts of these engineered consortia in diverse human populations, paving the way for innovative microbial therapies that promote overall health and well‐being.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomePrecision MedicineMicrobial ConsortiaHumansSynthetic BiologyAnimalsProbiotics

Stichwörter der Autor:innen

gut microbiome engineeringmicrobial consortiapersonalized medicinesynthetic biologytherapeutic microbiology

Autor:innen und Institutionen

  • Department of Environmental Engineering and Management, The University of Dodoma, Dodoma, Tanzania.

ORCID-Profile: Timoth Mkilima

Zitieren

APA

Mkilima, T. (2025). Engineering artificial microbial consortia for personalized gut microbiome modulation and disease treatment. Annals of the New York Academy of Sciences. https://doi.org/10.1111/nyas.15352

Vancouver

Mkilima T. Engineering artificial microbial consortia for personalized gut microbiome modulation and disease treatment. Annals of the New York Academy of Sciences. 2025. doi:10.1111/nyas.15352

BibTeX
@article{Mkilima2025,
  author = {Mkilima, Timoth},
  title = {Engineering artificial microbial consortia for personalized gut microbiome modulation and disease treatment},
  journal = {Annals of the New York Academy of Sciences},
  year = {2025},
  doi = {10.1111/nyas.15352}
}
Kostenlos starten →